[Skip to Navigation]
Article
May 1957

Ethchlorvynol (Placidyl) as a Sedative in Dermatological Practice

AMA Arch Derm. 1957;75(5):747-748. doi:10.1001/archderm.1957.01550170115022
Abstract

The ethchlorvynol (Placidyl, Abbott) was supplied by Abbott Laboratories, North Chicago, Ill.

The value of sedation, with and without psychotherapy, in the management of skin disorders is well recognized. Up to the present time, available drugs have been limited very largely to the barbiturates, but long-term treatment with these compounds may raise questions relating to habituation or even addiction. They may also cause toxic dermatological effects. For these reasons it was decided to evaluate the effects of ethchlorvynol (Placidyl) a new, nonbarbiturate sedative, as an aid in the management of skin disorders.

Present Study

No particular method of selection was used. The patients were those considered likely to benefit from sedation. Appropriate local treatment for the skin condition was used in every case. All the patients were adult, and there was no special preponderance of any age group or either sex. Often the skin condition improved

First Page Preview View Large
First page PDF preview
First page PDF preview
×